PEPTIDE POSSESSING MESENCHYMAL-STEM-CELL MOBILIZING ACTIVITY
The present inventors designed an artificial sequence peptide based on the results of original research conducted so far, and found that the peptide exhibits an activity of mobilizing mesenchymal stem cells into peripheral blood. The present inventors also found that the artificial sequence peptide...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
03.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present inventors designed an artificial sequence peptide based on the results of original research conducted so far, and found that the peptide exhibits an activity of mobilizing mesenchymal stem cells into peripheral blood. The present inventors also found that the artificial sequence peptide has a therapeutic effect on inflammatory bowel disease, atopic dermatitis, and cerebral infarction. Based on these findings, a new regenerative medicine technology that can overcome the problems of cell transplantation therapy is provided. |
---|---|
Bibliography: | Application Number: EP20190869158 |